2024
Journal - Research Article
Faiz, M., Kalev-Zylinska, M. L., Dunstan-Harrison, C., Singleton, D. C., Hay, M. P., & Ledgerwood, E. C. (2024). Megakaryocyte maturation involves activation of the adaptive unfolded protein response. Genes to Cells. Advance online publication. doi: 10.1111/gtc.13151
Dunstan-Harrison, C., Morison, I. M., & Ledgerwood, E. C. (2024). Inherited thrombocytopenia associated with a variant in the FLI1 binding site in the 5' UTR of ANKRD26. Clinical Genetics. Advance online publication. doi: 10.1111/cge.14547
Shafaei Pishabad, Z., & Ledgerwood, E. C. (2024). The Y49H cytochrome c variant enhances megakaryocytic maturation of K-562 cells. Biochimica et Biophysica Acta: Molecular Basis of Disease, 1870(5), 167134. doi: 10.1016/j.bbadis.2024.167134
Chin, T. C., Wilbanks, S. M., & Ledgerwood, E. C. (2024). Altered conformational dynamics contribute to species-specific effects of cytochrome c mutations on caspase activation. Journal of Biological Inorganic Chemistry. Advance online publication. doi: 10.1007/s00775-024-02044-2
Barzak, F. M., Lu, A., Geltzeiler, A. R., Ledgerwood, E. C., Chung, W. K., & Day, C. L. (2024). A novel RNF125 variant associated with Tenorio syndrome alters ubiquitin chain binding. Clinical Genetics, 105, 254-261. doi: 10.1111/cge.14457
2023
Journal - Research Article
Shafaei Pishabad, Z., Wan, Y. O. A., & Ledgerwood, E. (2023). A cytochrome c variant enhances megakaryocytic maturation. Blood, 142(Suppl. 1), 5591. doi: 10.1182/blood-2023-179186
Taylor, M. F., Black, M. A., Hampton, M. B., & Ledgerwood, E. C. (2023). Insights into H2O2-induced signaling in Jurkat cells from analysis of gene expression. Free Radical Research. Advance online publication. doi: 10.1080/10715762.2023.2165073
Conference Contribution - Published proceedings: Abstract
Lu, A., Kleffmann, T., Ledgerwood, E. C., & Day, C. L. (2023). Characterisation of the role of RNF125 in RIG-I antiviral signalling. Proceedings of the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB) 50th Anniversary Conference. Retrieved from https://www.nzsbmb.org/conference
Dunlop, J., Ledgerwood, E. C., & Mace, P. D. (2023). Developing targeted protein degradation to investigate the role of Tribbles in Acute Myeloid Leukaemia. Proceedings of the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB) 50th Anniversary Conference. Retrieved from https://www.nzsbmb.org/conference
MacTaggart, C., & Ledgerwood, E. (2023). Peroxiredoxin oxidation state in different blood cell types. Proceedings of the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB) 50th Anniversary Conference. Retrieved from https://www.nzsbmb.org/conference
Ledgerwood, E., King-Hudson, T.-R., Pearson, A., Dunstan-Harrison, C., & Hampton, M. (2023). Peroxiredoxins as markers of redox homeostasis in studies of human ageing. Free Radical Biology & Medicine, 208(Suppl. 1), 113. doi: 10.1016/j.freeradbiomed.2023.10.127
Voyce-McCulloch, S. E., & Ledgerwood, E. C. (2023). Understanding how peroxiredoxins provide specificity in redox signalling. In T. Milne, M. Anwar, L. Burga, H. Harcombe, M. Garelja, A. Middleton, D. C. Ribeiro, N. Fleming, K. Ogbuehi & A. Bahn (Eds.), Proceedings of the 265th Otago Medical School Research Society (OMSRS) Meeting: Summer Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
2022
Journal - Research Other
Dunstan-Harrison, C., Morison, I. M., & Ledgerwood, E. C. (2022). A novel frameshift GP1BB mutation causes autosomal dominant macrothrombocytopenia with decreased vWF receptor expression but normal platelet aggregation. Platelets, 33(2), 324-327. doi: 10.1080/09537104.2021.1909716
Conference Contribution - Published proceedings: Abstract
Faiz, M., Kalev-Zylinska, M., Kleffmann, T., Day, R., & Ledgerwood, E. C. (2022). Elevated Ca2+ flux plays a vital role in type I calreticulin mutations. In L. Wilson, H. Harcombe, P. Jayakaran, L. Burga, J. Antony, K. Morgaine, M. Garelja, A. Middleton, M. Anwar & T. Milne (Eds.), Proceedings of the 263rd Otago Medical School Research Society (OMSRS) Meeting: PhD Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Shafaei Pishabad, Z., & Ledgerwood, E. (2022). The effect of cytochrome c mutation on megakaryocyte differentiation. Proceedings of the ComBio Conference. (pp. 188). Retrieved from https://combio.org.au/combio2022/
Conference Contribution - Verbal presentation and other Conference outputs
Faiz, M., Kalev-Zylinska, M., Kleffmann, T., Day, R., & Ledgerwood, E. C. (2022, September). Elevated calcium flux plays a vital role in dual-guide CRISPR/Cas9 generated type I calreticulin mutant cells. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.
Faiz, M., Kalev-Zylinska, M., Kleffmann, T., Day, R., & Ledgerwood, E. C. (2022, August). Elevated endoplasmic reticulum calcium flux plays a vital role in dual-guide CRISPR/Cas9 generated type I calreticulin mutant cells. Verbal presentation at the CRISPR Technologies Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
2021
Journal - Research Article
Das, A., Middleton, A. J., Padala, P., Ledgerwood, E. C., Mace, P. D., & Day, C. L. (2021). The structure and ubiquitin binding properties of TRAF RING heterodimers. Journal of Molecular Biology, 433, 166844. doi: 10.1016/j.jmb.2021.166844
Fellner, M., Parakra, R., McDonald, K. O., Kass, I., Jameson, G. N. L., Willbanks, S. M., & Ledgerwood, E. C. (2021). Altered structure and dynamics of pathogenic cytochrome c variants correlate with increased apoptotic activity. Biochemical Journal, 478(3), 669-684. doi: 10.1042/bcj20200793
Conference Contribution - Published proceedings: Abstract
Dunstan-Harrison, C., Ledgerwood, E., & Morison, I. (2021). Determining the molecular and functional basis of inherited thrombocytopenia in New Zealand families. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 280). Retrieved from https://www.faobmb2021.org
Roydhouse, A., & Ledgerwood, L. (2021). Investigating the role of peroxiredoxins in putative life-span-increasing health interventions. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 251). Retrieved from https://www.faobmb2021.org
Shafaei, Z., Dunstan-Harrison, C., & Ledgerwood, E. (2021). Effects of oxygen concentration on megakaryocyte differentiation and maturation of K562, MEG01 and human primary cells. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 182). Retrieved from https://www.faobmb2021.org
Faiz, M., Kalev-Zylinska, M., & Ledgerwood, E. C. (2021). Investigating the role of unfolded protein response in megakaryocyte maturation. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 53). Retrieved from https://www.faobmb2021.org
Taylor, M., Black, M., Hampton, M., & Ledgerwood, L. (2021). Transcriptional response of Jurkat T lymphoma cells to hydrogen peroxide. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 276). Retrieved from https://www.faobmb2021.org
Faiz, M., Kalev-Zylinska, M., & Ledgerwood, E. (2021). Investigating the role of unfolded protein response in megakaryocyte maturation. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 28). [Abstract]
2020
Working Paper; Discussion Paper; Technical Report
Fellner, M., Parakra, R., McDonald, K. O., Kass, I., Jameson, G. N. L., Wilbanks, S. M., & Ledgerwood, E. C. (2020). Altered structure and dynamics of pathogenic cytochrome c variants correlate with increased apoptotic activity. bioRxiv. doi: 10.1101/2020.06.14.151373
2019
Journal - Research Other
Ledgerwood, E. C., Dunstan-Harrison, C., Ong, L., & Morison, I. M. (2019). CYCS gene variants associated with thrombocytopenia. Platelets, 30(5), 672-674. doi: 10.1080/09537104.2018.1543866
2018
Journal - Research Article
Parakra, R. D., Kleffmann, T., Jameson, G. N. L., & Ledgerwood, E. C. (2018). The proportion of Met80-sulfoxide dictates peroxidase activity of human cytochrome c. Dalton Transactions, 47, 9128. doi: 10.1039/c8dt02185f
Conference Contribution - Published proceedings: Abstract
Parakra, R., Kleffmann, T., Jameson, G., & Ledgerwood, E. (2018). Investigating peroxidase activity and cardiolipin oxidation in human cytochrome c variants. Free Radical Biology & Medicine, 120(Suppl. 1), (pp. S99). doi: 10.1016/j.freeradbiomed.2018.04.327
Conference Contribution - Poster Presentation (not in published proceedings)
Wood, G., & Ledgerwood, E. C. (2018, August). The rate of the peroxidase catalysed by cytochrome c is influenced by the oxidation of methionine 80. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Weijman, J. F., Mace, P. D., & Ledgerwood, E. C. (2018, August). Peroxiredoxin 1 contribution to hydrogen peroxide signalling. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2017
Journal - Research Article
Ong, L., McDonald, K. O., & Ledgerwood, E. C. (2017). Differentiation and cell density upregulate cytochrome c levels in megakaryoblastic cell lines: Implications for analysis of CYCS-associated thrombocytopenia. PLoS ONE, 12(12), e0190433. doi: 10.1371/journal.pone.0190433
Weijman, J. F., Kumar, A., Jamieson, S. A., King, C. M., Caradoc-Davies, T. T., Ledgerwood, E. C., … Mace, P. D. (2017). Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1. PNAS, 114(11), E2096-E2105. doi: 10.1073/pnas.1620813114
Ong, L., Morison, I. M., & Ledgerwood, E. C. (2017). Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes. British Journal of Haematology, 176(2), 268-279. doi: 10.1111/bjh.14421
Ledgerwood, E. C., Marshall, J. W. A., & Weijman, J. F. (2017). The role of peroxiredoxin 1 in redox sensing and transducing. Archives of Biochemistry & Biophysics, 617, 60-67. doi: 10.1016/j.abb.2016.10.009
Conference Contribution - Poster Presentation (not in published proceedings)
Weijman, J. F., Jamieson, S., Murphy, J. M., Ledgerwood, E. C., & Mace, P. D. (2017, September). Insights into apoptosis-signal regulating kinase 1 regulation. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Ledgerwood, E. (2017, December). Regulation of ASK1 activity by peroxiredoxin 1 and thioredoxin. Verbal presentation at the 8th Joint Meeting of Society for Free Radical Research Australasia and Japan with International Symposium on Coenzyme Q10, Tokyo, Japan.
Parakra, R., Jameson, G., & Ledgerwood, E. (2017, September). Relationship between cytochrome c and cardiolipin oxidation is highly dependent upon the experimental conditions. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Parakra, R., McDonald, K. O., Ong, L., Todd, P., Mohamad Nor, A., Morison, I. M., Jameson, G. N. L., & Ledgerwood, L. (2017, September). Insights into function from naturally occurring cytochrome c mutations. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2016
Conference Contribution - Published proceedings: Abstract
Ledgerwood, E., Weijman, J., Marshall, J., & Mace, P. (2016). Redox regulation of ASK1 by peroxiredoxin 1 and thioredoxin 1. Free Radical Biology & Medicine, 100(Suppl.), (pp. S42). doi: 10.1016/j.freeradbiomed.2016.10.109
2015
Journal - Research Article
Josephs, T. M., Hibbs, M. E., Ong, L., Morison, I. M., & Ledgerwood, E. C. (2015). Interspecies variation in the functional consequences of mutation of cytochrome c. PLoS ONE, 10(6), e0130292. doi: 10.1371/journal.pone.0130292
Conference Contribution - Published proceedings: Abstract
Ong, L., Morison, I. M., & Ledgerwood, E. C. (2015). Investigating the cause of thrombocytopenia cargeeg. Proceedings of the 27th National Conference on Microscopy. Retrieved from http://microscopy2015.otago.ac.nz/index.html
Conference Contribution - Poster Presentation (not in published proceedings)
Parakra, R. D., Jameson, G. N. L., & Ledgerwood, E. C. (2015, August-September). Investigating the peroxidase reaction mechanism of human cytochrome c. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Ledgerwood, L. (2015, December). Examining the role of peroxiredoxin 1 in redox signalling. Verbal presentation at the Society for Free Radical Research Australasia & Japan Seventh Joint Meeting, Christchurch, New Zealand.
2014
Journal - Research Article
Josephs, T. M., Morison, I. M., Day, C. L., Wilbanks, S. M., & Ledgerwood, E. C. (2014). Enhancing the peroxidase activity of cytochrome c by mutation of residue 41: Implications for the peroxidase mechanism and cytochrome c release. Biochemical Journal, 458(2), 259-265. doi: 10.1042/BJ20131386
Conference Contribution - Verbal presentation and other Conference outputs
Ledgerwood, L. (2014, September). Joining the dots from genotype to phenotype in a rare inherited thrombocytopenia. Verbal presentation at the Division of Health Sciences Research Forum: Learning Different Research Languages, Dunedin, New Zealand.
2013
Journal - Research Article
Josephs, T. M., Liptak, M. D., Hughes, G., Lo, A., Smith, R. M., Wilbanks, S. M., … Ledgerwood, E. C. (2013). Conformational change and human cytochrome c function: Mutation of residue 41 modulates caspase activation and destabilizes Met-80 coordination. Journal of Biological Inorganic Chemistry, 18, 289-297. doi: 10.1007/s00775-012-0973-1
Conference Contribution - Poster Presentation (not in published proceedings)
Vick, K. A., Betz, A., O'Connor, K. M., Hughes, S. M., Ledgerwood, E. C., & Hampton, M. B. (2013, August). Functional consequences of lowering mitochondrial peroxiredoxin 3 expression. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Ong, L., Josephs, T. M., & Ledgerwood, E. C. (2013, August). Investigations into a cytochrome c variant that causes thrombocytopenia. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Ledgerwood, L. (2013, September). Peroxidase activity of a human cytochrome c variant: Implications for the peroxidase mechanism and apoptosis. Verbal presentation at the 8th International Human Peroxidase Meeting, Sydney, Australia.
Josephs, T. M., Morison, I. M., Wilbanks, S. M., Bren, K., & Ledgerwood, E. C. (2013, August). Cytochrome c mutations: Biochemistry and physiology. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2012
Journal - Research Article
Jarvis, R. M., Hughes, S. M., & Ledgerwood, E. C. (2012). Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells. Free Radical Biology & Medicine, 53(7), 1522-1530. doi: 10.1016/j.freeradbiomed.2012.08.001
Conference Contribution - Published proceedings: Abstract
Josephs, T. M., Morison, I. M., Wilbanks, S. M., & Ledgerwood, E. C. (2012). Cytochrome c peroxidase activity and mitochondrial release during apoptosis. Proceedings of the Oxygen Theme Meeting. (pp. 16). Dunedin, New Zealand: University of Otago. Retrieved from https://www.otago.ac.nz/research/otago051864.pdf
2011
Journal - Research Article
Bordé, E. C., Ouzegdouh, Y., Ledgerwood, E. C., & Morison, I. M. (2011). Congenital thrombocytopenia and cytochrome c mutation: A matter of birth and death. Seminars in Thrombosis & Hemostasis, 37(6), 664-672. doi: 10.1055/s-0031-1291376
Liptak, M. D., Fagerlund, R. D., Ledgerwood, E. C., Wilbanks, S. M., & Bren, K. (2011). The proapoptotic G41S mutation to human cytochrome c alters the heme electronic structure and increases the electron self-exchange rate. Journal of the American Chemical Society, 133(5), 1153-1155. doi: 10.1021/ja106328k
2010
Journal - Research Article
Porteous, C. M., Logan, A., Evans, C., Ledgerwood, E. C., Menon, D. K., Aigbirhio, F., Smith, R. A. J., & Murphy, M. P. (2010). Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: Implications for mitochondria-specific therapies and probes. Biochimica et Biophysica Acta: General Subjects, 1800(9), 1009-1017. doi: 10.1016/j.bbagen.2010.06.001
Conference Contribution - Poster Presentation (not in published proceedings)
Josephs, T., Fagerlund, R., Hughes, G., Morison, I., Wilbanks, S., & Ledgerwood, L. (2010, September). Does the first naturally occurring mutation of Cytochrome C challenge the current understanding of apoptosis? Poster session presented at the Fourth Annual Division of Health Sciences Research Forum, Dunedin, New Zealand.
Other Research Output
Ledgerwood, E. (2010, December). Understanding cell death and platelet formation: Insights from a mutation in cytochrome c. University of Otago Department of Biochemistry Seminar, Dunedin, New Zealand. [Department Seminar].
2009
Journal - Research Article
Westphal, D., Ledgerwood, E. C., Tyndall, J. D. A., Hibma, M. H., Ueda, N., Fleming, S. B., & Mercer, A. A. (2009). The orf virus inhibitor of apoptosis functions in a Bcl-2-like manner, binding and neutralizing a set of BH3-only proteins and active Bax. Apoptosis, 14(11), 1317-1330. doi: 10.1007/s10495-009-0403-1
Ledgerwood, E. C., & Morison, I. M. (2009). Targeting the apoptosome for cancer therapy. Clinical Cancer Research, 15(2), 420-424. doi: 10.1158/1078-0432.CCR-08-1172
2008
Journal - Research Article
Cox, A. G., Pullar, J. M., Hughes, G., Ledgerwood, E. C., & Hampton, M. B. (2008). Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radical Biology & Medicine, 44(6), 1001-1009. doi: 10.1016/j.freeradbiomed.2007.11.017
Morison, I. M., Cramer Bordé, E. M., Cheesman, E. J., Cheong, P. L., Holyoake, A. J., Fichelson, S., Weeks, R. J., Lo, A., Davies, S. M. K., Wilbanks, S. M., Fagerlund, R. D., Ludgate, M. W., da Silva Tatley, F. M., Coker, M. S. A., Bockett, N. A., Hughes, G., Pippig, D. A., Smith, M. P., … Ledgerwood, E. C. (2008). A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nature Genetics, 40(4), 387-389. doi: 10.1038/ng.103
Conference Contribution - Published proceedings: Abstract
Morison, I., Ledgerwood, E. C., Cramer, E. M., Cheong, P. L., Hughes, G., Holyoake, A. J., & Fichelson, S. (2008). Familial thrombocytopenia caused by a pro-apoptotic mutation of cytochrome C. Haematologica, 93(Suppl. 1), (pp. 119). [Abstract]
Conference Contribution - Verbal presentation and other Conference outputs
Ledgerwood, E. (2008, November). Modulating inflammatory gene expression by manipulating the mitochondrial redox state. Verbal presentation at the Society for Free Radical Research Australasia Conference, Melbourne, Australia.
2007
Journal - Research Article
Jarvis, R. M., Göttert, J., Murphy, M. P., & Ledgerwood, E. C. (2007). Mitochondria-targeted antioxidants do not prevent tumour necrosis factor-induced necrosis of L929 cells. Free Radical Research, 41(9), 1041-1046.
Westphal, D., Ledgerwood, E. C., Hibma, M. H., Fleming, S. B., Whelan, E. M., & Mercer, A. A. (2007). A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus orf virus. Journal of Virology, 81(13), 7178-7188.
Conference Contribution - Published proceedings: Abstract
Jarvis, R., & Ledgerwood, E. (2007). Mitochondrial redox-active species participate in the modulation of nuclear gene expression. New Zealand Medical Journal, 120(1262). Retrieved from http://journal.nzma.org.nz/journal/120-1262/2740/content.pdf
Cox, A. G., Pullar, J. M., Hughes, G., Ledgerwood, E. C., & Hampton, M. B. (2007). Mitochondrial peroxiredoxin 3 is oxidized during Fas and TNF-a mediated apoptosis. Proceedings of the American Association for Cancer Research (AACR) 98th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/
Westphal, D., Ledgerwood, E., Fleming, S., & Mercer, A. (2007). The orf virus protein ORFV125 acts in a Bcl-2-like manner to inhibit apoptosis. New Zealand Medical Journal, 120(1262). Retrieved from http://journal.nzma.org.nz/journal/120-1262/2740/content.pdf
2006
Conference Contribution - Published proceedings: Abstract
Westphal, D., Fleming, S. B., Ledgerwood, E. C., & Mercer, A. A. (2006). The orf virus protein ORFV125 is a potent inhibitor of apoptosis. New Zealand Medical Journal, 119(1237). Retrieved from http://journal.nzma.org.nz/journal/119-1237/2062/content.pdf
2005
Journal - Research Article
Hughes, G., Murphy, M. P., & Ledgerwood, E. C. (2005). Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor κB to modulate tumour necrosis factor-induced apoptosis: Evidence from mitochondria-targeted antioxidants. Biochemical Journal, 389, 83-89.
Conference Contribution - Poster Presentation (not in published proceedings)
Lecomte, F. J. L., Hubbard, M. J., & Ledgerwood, E. C. (2005, September). Knocking down of ERp29: A means to uncover its function? Poster session presented at the 15th Annual Queenstown Molecular Biology Meeting, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Westphal, D., Ledgerwood, E. C., Whelan, E. M., Fleming, S. B., Hibma, M. H., & Mercer, A. A. (2005, November). Characterisation of a novel inhibitor of apoptosis expressed by orf virus. Verbal presentation at the SBMB New Zealand and the NZMS Conference: Celebrating 50 years of Microbial Interactions, Dunedin, New Zealand.
2004
Conference Contribution - Verbal presentation and other Conference outputs
Mercer, A., Whelan, E., Westphal, D., Hibma, M., Fleming, S., & Ledgerwood, E. (2004, September). Inhibition of apoptosis by orf virus: Contribution of a unique, mitochondrial targeted factor. Verbal presentation at the XVth International Poxvirus and Iridovirus Conference, Oxford, England.
2003
Journal - Research Article
Smith, R. A. J., Kelso, G. F., Blaikie, F. H., Porteous, C. M., Ledgerwood, E. C., Hughes, G., … Filipovska, A., & Murphy, M. P. (2003). Using mitochondria-targeted molecules to study mitochondrial radical production and its consequences. Biochemical Society Transactions, 31, 1295-1299.
2002
Journal - Research Article
Kelso, G. F., Porteous, C. M., Hughes, G., Ledgerwood, E. C., Gane, A. M., Smith, R. A. J., & Murphy, M. P. (2002). Prevention of Mitochondrial Oxidative Damage Using Targeted Antioxidants. Annals of the New York Academy of Sciences, 959, 263-274.
2001
Journal - Research Article
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001). Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapopotic properties. Journal of Biological Chemistry, 276(7), 4588-4596.
2000
Journal - Research Article
Ledgerwood, E. C., O'Rahilly, S., & Surani, M. A. (2000). The imprinted gene Peg3 is not essential for tumor necrosis factor alpha signaling. Laboratory Investigation, 80, 1509-1511.
Ledgerwood, E. C., O'Rahilly, S., & Surani, M. A. (2000). The imprinted gene Peg3 is not essential for tumour necrosis factor alpha signaling. Laboratory Investigation, 80(10), 1509-1511.
Scarlett, J. L., Sheard, P. W., Hughes, G., Ledgerwood, E. C., Ku, H.-H., & Murphy, M. P. (2000). Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Letters, 475, 267-272.
1999
Chapter in Book - Research
Ledgerwood, E. C., & Prins, J. B. (1999). Tumour necrosis factor alpha. In S. M. Marshall, P. D. Home & R. A. Rizza (Eds.), The Diabetes Annual. (12 ed.) (pp. 161-180). Amsterdam: Elsevier.
Journal - Research Article
Ledgerwood, E. C., Pober, J. S., & Bradley, J. R. (1999). Recent advances in the molecular basis of TNF signal transduction. Laboratory Investigation, 79, 1041-1050.
Faraco, P. R., Ledgerwood, E. C., Vandenabeele, P., Prins, J. B., & Bradley, J. R. (1999). Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochemical & Biophysical Research Communications, 261, 385-392.
Jones, S. J., Ledgerwood, E. C., Prins, J. B., Galbraith, J., Johnson, D. R., Pober, J. S., & Bradley, J. S. (1999). TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principle subcellular location of TNF-R1. Journal of Immunology, 162, 1042-1048.
1998
Journal - Research Article
Ledgerwood, E. C., Prins, J. B., Bright, N. A., Johnson, D. R., Wolfreys, K., Pober, J. S., … Bradley, J. R. (1998). Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. Laboratory Investigation, 78, 1583-1589.
Prins, J. B., Ledgerwood, E. C., & et al (1998). Tumor necrosis factor-induced cytotoxicity is not related to rates of mitochondiral morphological abnormalities or authophage - chnages trhat can be mediated by TNFR-I or TNFR-II. Bioscience Reports, 18, 329-340.
Faraco, P. R., Ledgerwood, E. C., & Smith, K. G. C. (1998). Apoptosis in renal disease. Sepsis, 2, 31-37.
Min, W., Bradley, J. R., Savidge, J., Jones, S. J., Ledgerwood, E. C., & Pober, J. S. (1998). The N-terminal domains target TRAF2 to the nucleus and display transcriptional regulatory activity. Journal of Immunology, 161, 319-324.
Conference Contribution - Published proceedings: Abstract
Ledgerwood, E. C., & et al (1998). Tumor necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein. Biochemical Society Transactions. 26, (pp. S316). [Abstract]
1997
Journal - Research Article
Ledgerwood, E. C., Brennan, S. O., & George, P. M. (1997). Endoproteases other than furin have a role in hepatic proprotein processing. Biochemistry & Molecular Biology International, 42(6), 1131-1142.
1996
Journal - Research Article
Ledgerwood, E. C., Brennan, S. O., Birch, N. P., & George, P. M. (1996). The specificity of the neuroendocrine convertase PC3 is determined by residues NH2-and COOH-terminal to the cleavage site. Biochemistry & Molecular Biology International, 39(6), 1167-1176. doi: 10.1080/15216549600201352
Ledgerwood, E. C., Brennan, S. O., Cawley, N. X., Loh, Y. P., & George, P. M. (1996). Yeast aspartic protease 3 (Yap3) prefers substrates with basic residues in the P2, P1 and P2' positions. FEBS Letters, 383(1-2), 67-71. doi: 10.1016/0014-5793(96)00219-0
1995
Chapter in Book - Research
Ledgerwood, E. C., & Brennan, S. (1995). Furin. In A. Haeberli (Ed.), Human Protein Data: 3rd Instalment. VCH: Weinheim and New York.
Journal - Research Article
Hill, R. M., Ledgerwood, E. C., Brennan, S., Pu, L. P., Loh, Y. P., Christie, D., & Birch, N. P. (1995). Comparison of the molecular forms of the Kex2/subtilisin-like serine proteases SPC2, SPC3, and furin in neuroendocrine secretory vesicles reveals differences in carboxyl-terminus truncation and membrane association. Journal of Neurochemistry, 65, 2318-2326.